See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173281_2018_NeuBase_Therapeutics_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001173281', 'EntityCommonStockSharesOutstanding': 56196428, 'Assets': 27928877, 'AssetsCurrent': 13024363, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 14828514, 'Liabilities': 5083912, 'LiabilitiesAndStockholdersEquity': 27928877, 'LiabilitiesCurrent': 4933912, 'LiabilitiesNoncurrent': 0, 'NetIncome': -23810996, 'PropertyPlantAndEquipmentNet': 63757, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 12243, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 150000, 'remainder_LiabilitiesAndStockholdersEquity': 22844965, 'remainder_NetIncome': -23810996, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001173281')"} |
Edgar->Model Mapping
